Impact of maternal physical activity on birth biology and cord blood markers
Official title: Impact of Physical Activity During Pregnancy on Biological Markers at Birth in Cord Blood (CORDOMOUV)
Run by University Hospital, Clermont-Ferrand · NCT07579468 · Data updated 2026-11-12
This study looks at whether a mother's physical activity during pregnancy affects biological markers in the newborn, using cord blood samples.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Day to 2 Days |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Status | Recruiting |
| Started | May 5, 2026 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT07579468 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Newborns whose mothers participated in the PregMouv physical activity program and were delivered at Clermont-Ferrand University Hospital.
✕Probably not a fit
Parents who declined cord blood collection or where legal protections prevented collection may not contribute to or benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project analyzes cord blood from newborns whose mothers participated in a pregnancy physical activity program at Clermont-Ferrand University Hospital. It seeks to explore associations between maternal activity and biological markers at birth, including inflammatory markers related to neonatal health. Although related interventional work exists, this activity-focused research observes real-world outcomes from the PregMouv program and the birth cohort. The study builds on evidence that regular physical activity during pregnancy can benefit both mother and baby, and it examines potential links to neonatal health risks such as sepsis. No interventional arm is described within this observational analysis, and results will inform future research directions.
Why it matters
Potential benefit: If successful, findings could help refine expectations about how maternal activity influences newborn biology and early health indicators.
How similar studies have gone: Other studies have suggested beneficial links between maternal activity and neonatal health, supporting the relevance of examining cord blood biomarkers in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newborns born to mothers who participated in the PregMouv study (which aims to evaluate an intervention allowing women to better adhere to physical activity: program free/face-to-face/videoconference/mixed) and born at the Clermont Ferrand University Hospital. Exclusion Criteria: * If parents refuse to participate or in situations where parents are protected by law, cord blood collection cannot be done.
Where it's running
-
CHU de Clermont-Ferrand
Clermont-Ferrand, France Recruiting
Study contacts
- Principal investigator: Solène FEL — University Hospital, Clermont-Ferrand
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +334752963
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.